PUBLISHER: Lucintel | PRODUCT CODE: 1416732
PUBLISHER: Lucintel | PRODUCT CODE: 1416732
The future of the global biopsy device market looks promising with opportunities in the breast biopsy, lung biopsy, colorectal biopsy, and prostate biopsy markets. The global biopsy device market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and increasing demand for minimally invasive procedures.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global biopsy device by product, guidance technique, application, end use, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopsy device companies profiled in this report include-
Lucintel forecasts that needle-based biopsy instrument is expected to witness the highest growth over the forecast period.
Within this market, breast biopsy is expected to witness the highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period.
Market Size Estimates: Biopsy device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Biopsy device market size by various segments, such as by product, guidance technique, application, end use, and region in terms of value ($B).
Regional Analysis: Biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, guidance techniques, applications, end uses, and regions for the biopsy device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopsy device market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
Q1. What is the biopsy device market size?
Answer: The global biopsy device market is expected to reach an estimated $3.7 billion by 2030.
Q2. What is the growth forecast for biopsy device market?
Answer: The global biopsy device market is expected to grow with a CAGR of 6.6% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the biopsy device market?
Answer: The major drivers for this market are rising prevalence of cancer and increasing demand for minimally invasive procedures.
Q4. What are the major segments for biopsy device market?
Answer: The future of the biopsy device market looks promising with opportunities in the breast biopsy, lung biopsy, colorectal biopsy, and prostate biopsy markets.
Q5. Who are the key biopsy device market companies?
Answer: Some of the key biopsy device companies are as follows:
Q6. Which biopsy device market segment will be the largest in future?
Answer: Lucintel forecasts that needle-based biopsy instrument is expected to witness the highest growth over the forecast period.
Q7. In biopsy device market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.